HGH, GRENAA A/S: Financial statements 2021
CVR: 33120753
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
HGH, GRENAA A/S (CVR 33120753) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -9,386 compared with DKK -346,273 the year before. Equity in the 2021 report amounted to DKK 789,607. The solvency ratio was 54.5%.
- Profit/Loss
- DKK -9,386
- Equity
- DKK 789,607
- Total Assets
- DKK 1,447,602
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -9K | 790K | 0 |
| 2020 | - | - | -346K | 799K | 0 |
| 2019 | - | - | -252K | 1.1M | - |
| 2018 | - | - | -72K | 1.4M | - |
| 2017 | - | - | -306K | 1.5M | - |
Official annual report
Find more companies like HGH, GRENAA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
HGH, GRENAA A/S has published its annual report for 2020. The net result was DKK -346,273.
About HGH, GRENAA A/S
HGH, GRENAA A/S is a Danish company of the type Aktieselskab based in Grenaa, founded in 2010. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Louise Rørbæk Jensen. The board consists of Mette Rørbæk Jensen (chair), Jess Stegger and Louise Rørbæk Jensen. The company is owned by Boet efter Ulla Merethe Rørbæk Jensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,125 and a net result of DKK -1,506,927 compared with DKK 84,836 the year before. Equity in the 2025 report amounted to DKK -789,690.